AU:BDX Stock Latest News
Company AnnouncementsBCAL Outlines Conditions for Potential GSS-MAP Merger Support1d agoBDX
Company AnnouncementsBCAL Diagnostics Notifies Issue of Unquoted Convertible Notes2d agoBDX
Company AnnouncementsBCAL Diagnostics Director Jayne Shaw Acquires 67,685 Shares2d agoBDX
Company AnnouncementsBCAL Diagnostics Reports Cessation of 1,034,243 Options1w agoBDX
Company AnnouncementsBCAL Diagnostics Reports Cessation of 3,583,583 Performance Rights1w agoBDX
Company AnnouncementsBCAL Diagnostics Seeks Quotation of 1,383,750 Ordinary Securities1w agoBDX
Company AnnouncementsBCAL advances breast cancer and multicancer blood tests ahead of national rollout3w agoBDX
Company AnnouncementsBCAL backs Melki’s GSS board return but challenges Microba merger terms3w agoBDX
Company AnnouncementsBCAL Diagnostics Showcases BREASTESTplus 2 Research at Global Lipidomics Conference1M agoBDX
Company AnnouncementsBCAL Diagnostics Evolves Into National Early Cancer Detection Platform1M agoBDX
Company AnnouncementsBCAL Diagnostics Clinically Validates BREASTESTplus 2 Ahead of National Launch1M agoBDXCompany AnnouncementsBCAL Diagnostics Sets October AGM, Streamlines Digital Shareholder Participation2M agoBDX
Company AnnouncementsBCAL Diagnostics distances itself from merger talk as it pursues scale and synergies2M agoBDX
Company AnnouncementsBCAL Diagnostics pushes for board shake‑up at Genetic Signatures after lifting stake2M agoBDX
Company AnnouncementsBCAL Diagnostics Builds Early Cancer Detection Platform as Test Uptake Grows2M agoBDX
Company AnnouncementsBCAL Diagnostics Files Updated Corporate Governance Statement with ASX2M agoBDX
Company AnnouncementsBCAL Diagnostics widens early cancer platform as losses deepen and balance sheet weakens2M agoBDXCompany AnnouncementsBCAL Diagnostics boosts Genetic Signatures stake to deepen diagnostics platform2M agoBDX


